查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1616710

心房颤动设备市场机会、成长驱动因素、产业趋势分析与预测 2024 - 2032 年

Atrial Fibrillation Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 100 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023 年，全球心房颤动设备市场估值为 106 亿美元，预计 2024 年至 2032 年复合年增长率为 11.5%。来越多采用心臟消融手术，并提高了对早期诊断的意识。心房颤动的发生率在全球范围内呈上升趋势，使其成为最常见的心律不整类型。影响因素包括人口老化以及肥胖、高血压和其他心血管疾病发生率的增加。全球有数百万人受到影响，对诊断和治疗设备的需求正在增加。

患者和医疗保健提供者对心房颤动的认识不断提高，可以更及时地进行诊断和治疗。公共卫生措施和教育活动强调了监测和管理 AF 的重要性，从而增加了对 AF 设备的需求。早期检测对于预防中风等併发症至关重要，这反过来又推动了诊断和监测工具的使用。心房颤动设备是用于诊断、监测和治疗 AFib（一种常见的心律不整）的重要医疗工具。

其中包括用于除颤器的导管、植入式心臟监视器、消融手术以及帮助调节心律的心律调节器。他们的主要目标是恢復正常的心臟功能、预防中风和缓解心房颤动相关症状。这些设备在 AFib 患者的急性和长期治疗中发挥着至关重要的作用。市场按产品细分，包括心臟监视器、电生理消融导管、标测系统、电生理诊断导管、接取装置、左心耳封堵装置、心内超音波心臟检查 (ICE) 和其他相关产品。

市场范围
开始年份 2023年
预测年份 2024-2032
起始值 106 亿美元
预测值 279 亿美元
复合年增长率 11.5%

电生理消融导管部门获得了最高的收入，这得益于提高消融手术安全性和有效性的技术进步。导管设计的创新和改进的能量输送系统扩大了可以从消融中受益的患者范围，进一步推动了市场成长。就最终用途而言，心房颤动设备市场分为门诊手术中心、医院、心臟中心等。由于对需要各种 AF 设备进行诊断、治疗和患者监护的专业治疗中心的需求不断增长，医院细分市场将在 2023 年引领市场。

北美房颤设备市场 2023 年收入达 43 亿美元，预计 2024 年至 2032 年复合年增长率为 11.3%。北美的高医疗保健支出支持对先进医疗技术（包括心房颤动设备）的大量投资，刺激了市场成长。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 先进技术的高采用率和先进的医疗基础设施
      • 心血管疾病盛行率增加
      • 老年人口不断增加
      • 风湿性瓣膜性心臟病盛行率上升
    • 产业陷阱与挑战
      • 与心房颤动设备相关的高成本
      • 发展中国家对增强医疗技术缺乏认识
  • 成长潜力分析
  • 监管环境
  • 技术景观
  • 报销场景
  • 2021 - 2023 年全球和区域层面的心房颤动导管消融手术
    • 全球的
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 导管消融中心，依地区划分，2021 - 2023
    • 全球的
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • MEA
  • 定价分析
  • 差距分析
  • 波特的分析
  • PESTEL分析

第 4 章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章：市场估计与预测：按产品分类，2021 - 2032 年

  • 主要趋势
  • EP消融导管
    • 射频 (RF)
    • 雷射
    • 冷冻消融
    • 超音波
    • 微波
    • 其他 EP 消融导管
  • 心臟监测仪或植入式循环记录仪
  • EP诊断导管
    • 先进的标测导管
    • 可操纵导管
    • 固定曲线导管
  • 测绘和记录系统
  • 存取装置
  • 心内超音波心动图（ICE）
  • 左心耳 (LAA) 封堵器
  • 其他产品

第 6 章：市场估计与预测：按最终用途分类，2021 - 2032 年

  • 主要趋势
  • 医院
  • 心臟中心
  • 门诊手术中心
  • 其他最终用户

第 7 章：市场估计与预测：按地区，2021 - 2032

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区

第 8 章：公司简介

  • Abbott Laboratories
  • Acutus Medical, Inc.
  • AtriCure, Inc.
  • Biotronik
  • Boston Scientific Corporation
  • CardioFocus
  • CathRx Ltd.
  • Hansen Medical, Inc.
  • Imricor
  • Johnson and Johnson (Biosense Webster)
  • Medtronic plc
  • MicroPort Scientific Corporation
  • OSYPKA MEDICAL
  • Stryker Corporation
  • Synaptic Medical
简介目录
Product Code: 3165

The Global Atrial Fibrillation Devices Market was valued at USD 10.6 billion in 2023 and is projected to grow at a CAGR of 11.5% from 2024 to 2032. This robust growth is primarily driven by advancements in atrial fibrillation devices, a rising prevalence of AF, an increasing adoption of cardiac ablation procedures, and heightened awareness leading to early diagnosis. The incidence of atrial fibrillation is on the rise globally, making it the most common type of cardiac arrhythmia. Contributing factors include aging populations and increasing rates of obesity, hypertension, and other cardiovascular conditions. With millions affected worldwide, the demand for both diagnostic and treatment devices is escalating.

Increased awareness about atrial fibrillation among patients and healthcare providers has led to more timely diagnoses and treatment. Public health initiatives and educational campaigns highlight the importance of monitoring and managing AF, boosting demand for AF devices. Early detection is crucial to preventing complications like stroke, which in turn drives the use of diagnostic and monitoring tools. Atrial fibrillation devices are essential medical tools used to diagnose, monitor, and treat AFib, a common heart rhythm disorder.

These include catheters for defibrillators implantable cardiac monitors, ablation procedures, and pacemakers that help regulate heart rhythm. Their main goals are to restore normal heart function, prevent strokes, and alleviate AFib-related symptoms. These devices play a vital role in both the acute and long-term management of AFib patients. The market is segmented by product, including cardiac monitors, EP ablation catheters, mapping systems, EP diagnostic catheters, access devices, left atrial appendage closure devices, intracardiac echocardiography (ICE), and other related products.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$10.6 Billion
Forecast Value$27.9 Billion
CAGR11.5%

The EP ablation catheters segment garnered the highest revenue, driven by technological advancements that enhance safety and efficacy in ablation procedures. Innovations in catheter design and improved energy delivery systems have expanded the range of patients who can benefit from ablation, further propelling market growth. In terms of end-use, the atrial fibrillation devices market is divided into ambulatory surgical centers, hospitals, cardiac centers, and others. The hospitals segment led the market in 2023, fueled by the increasing need for specialized treatment centers that require a variety of AF devices for diagnosis, treatment, and patient monitoring.

The North America atrial fibrillation devices market amassed USD 4.3 billion in revenue in 2023 and is expected to grow at a CAGR of 11.3% from 2024 to 2032. This region's high prevalence of AF is influenced by an aging population and a rise in lifestyle-related conditions. High healthcare expenditure in North America supports significant investments in advanced medical technologies, including atrial fibrillation devices, stimulating market growth.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 High adoption rate of advanced technologies and presence of sophisticated healthcare infrastructure
      • 3.2.1.2 Increase in prevalence of cardiovascular diseases
      • 3.2.1.3 Rising geriatric population
      • 3.2.1.4 Rise in prevalence of rheumatic valvular heart diseases
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost associated with atrial fibrillation devices
      • 3.2.2.2 Lack of awareness regarding enhanced medical technologies in developing countries
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technology landscape
  • 3.6 Reimbursement scenario
  • 3.7 Atrial fibrillation catheter ablation procedures at global and regional level, 2021 - 2023
    • 3.7.1 Global
    • 3.7.2 North America
    • 3.7.3 Europe
    • 3.7.4 Asia Pacific
    • 3.7.5 Latin America
    • 3.7.6 Middle East & Africa
  • 3.8 Catheter ablation centres, by region, 2021 - 2023
  • 3.9 Atrial fibrillation devices market, 2021 -2032 (Units)
    • 3.9.1 Global
    • 3.9.2 North America
    • 3.9.3 Europe
    • 3.9.4 Asia Pacific
    • 3.9.5 Latin America
    • 3.9.6 MEA
  • 3.10 Pricing analysis
  • 3.11 Gap analysis
  • 3.12 Porter's analysis
  • 3.13 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 EP ablation catheters
    • 5.2.1 Radiofrequency (RF)
    • 5.2.2 Laser
    • 5.2.3 Cryoablation
    • 5.2.4 Ultrasound
    • 5.2.5 Microwave
    • 5.2.6 Other EP ablation catheters
  • 5.3 Cardiac monitors or implantable loop recorder
  • 5.4 EP diagnostic catheters
    • 5.4.1 Advanced mapping catheters
    • 5.4.2 Steerable catheters
    • 5.4.3 Fixed curve catheters
  • 5.5 Mapping and recording systems
  • 5.6 Access devices
  • 5.7 Intracardiac echocardiography (ICE)
  • 5.8 Left atrial appendage (LAA) closure devices
  • 5.9 Other products

Chapter 6 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Hospitals
  • 6.3 Cardiac centers
  • 6.4 Ambulatory surgical centers
  • 6.5 Other end-users

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Spain
    • 7.3.5 Italy
    • 7.3.6 Netherlands
    • 7.3.7 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 South Korea
    • 7.4.6 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
    • 7.5.4 Rest of Latin America
  • 7.6 Middle East and Africa
    • 7.6.1 South Africa
    • 7.6.2 Saudi Arabia
    • 7.6.3 UAE
    • 7.6.4 Rest of Middle East and Africa

Chapter 8 Company Profiles

  • 8.1 Abbott Laboratories
  • 8.2 Acutus Medical, Inc.
  • 8.3 AtriCure, Inc.
  • 8.4 Biotronik
  • 8.5 Boston Scientific Corporation
  • 8.6 CardioFocus
  • 8.7 CathRx Ltd.
  • 8.8 Hansen Medical, Inc.
  • 8.9 Imricor
  • 8.10 Johnson and Johnson (Biosense Webster)
  • 8.11 Medtronic plc
  • 8.12 MicroPort Scientific Corporation
  • 8.13 OSYPKA MEDICAL
  • 8.14 Stryker Corporation
  • 8.15 Synaptic Medical